课题基金 / 基金详情

基于DNA合成银纳米团簇的色氨酸光化学传感体系构建及其在脓毒症时相鉴别中的应用

批准号:
82102507
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张晶璞
依托单位:
学科分类:
检验医学研究新技术与新方法
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张晶璞

项目摘要

结项摘要

相似基金

相关文献

中文摘要
脓毒症进展阶段以炎症因子为主的时相变化复杂,而其临床鉴别缺失,导致精准治疗难度加大,亟需寻找脓毒症时相鉴别标志物及相应便捷检测方法。我们前期研究证实色氨酸耗竭导致持续性免疫抑制状态,是炎症时相转换的重要机制,提示可以色氨酸为标志物指示脓毒症时相变化。但是现有基于色谱的色氨酸检测,仪器操作复杂,难以临床普及。本研究拟开发色氨酸检测的纳米新技术用于脓毒症时相鉴别。我们前期通过构建含色氨酸适配体的发夹型捕获探针及相应DNA合成银纳米团簇信号探针,发现了色氨酸-银纳米团簇/DNA荧光增强效应。我们拟进一步分析该体系光化学反应特性,及其响应色氨酸的灵敏度和特异性,进而建立血浆游离色氨酸、总色氨酸及其载体白蛋白的联合检测方法。最后,对比传统检测技术,通过临床样本验证,评估新体系用于脓毒症时相鉴别的有效性。该光化学传感体系灵敏特异,且在普通荧光酶标仪上即可进行,将为脓毒症时相鉴别提供便捷经济的检测技术。
英文摘要
The phases characterized by inflammatory factors intricately change in the progress of sepsis, but the lack of phase distinguishing makes it more difficult to conduct targeted therapy. It is urgently needed to seek for biomarkers for phase distinguishing of sepsis and develop a convenient detection method of these biomarkers. Our study previously validated that tryptophan depletion leads to persistent immune suppression, which is the underlying key mechanism of inflammatory phase switching, suggesting that tryptophan would be a biomarker to indicate the phase changes of sepsis. However, the current tryptophan detection technology based on chromatography is hard to be popularized for clinical use due to the difficulty in instrument operation. We intend to develop a novel nano - technology to detect tryptophan for sepsis phase distinguishing. In our preliminary experiment, the fluorescence enhancement effect of tryptophan-AgNCs / DNA (DNA-templated silver nanoclusters) was found by establishing a capture probe containing a tryptophan aptamer and the corresponding signal probe AgNCs/DNA. The photochemical reaction properties of the tryptophan-AgNCs/DNA system will further be analyzed, as well as its sensitivity and specificity for tryptophan response. And then, the combined detection method respectively for free tryptophan, total tryptophan and its carrier-albumin will be determined. After the comparison with the traditional method by the validation of clinical sample, the effectiveness of the developed novel system for sepsis phase distinguishing will finally be evaluated. The photochemical sensing system of tryptophan-AgNCs/DNA can be conducted in the common fluorescence microplate reader with high sensitivity and specificity, therefore, would provide a convenient and economic technology to distinguish sepsis phases.
脓毒症进展阶段以炎症因子为主的时相变化复杂,而其临床鉴别缺失,亟需寻找脓毒症时相鉴别标志物及相应便捷检测方法。我们前期研究证实色氨酸耗竭导致持续性免疫抑制状态,是炎症时相转换的重要机制,提示可以色氨酸为标志物指示脓毒症时相变化。但是现有基于色谱的色氨酸检测,仪器操作复杂,难以临床普及。本研究主要构建了一种新型光化学传感体系进行色氨酸及其载体白蛋白HSA的联合检测,以期用于脓毒症时相鉴别。该体系由含富C序列的DNA合成银纳米团簇信号探针AgNCs/ShC,以及含色氨酸适配体与富G垂悬序列的发夹型捕获探针HpG组成。我们发现在紫外照射下色氨酸可触发富G序列依赖的AgNCs/ShC的荧光增强效应。该效应借助紫外照射提供的能量诱发结合在DNA上的有限色氨酸和银离子Ag+间发生氧化还原反应,进而生成了荧光银纳米团簇。基于这一光化学反应特性,该纳米传感体系检测色氨酸的线性范围为0.05 ~ 60 μM,最低检测限LOD为0.43μM,优于现有的基于荧光的检测方法,并且其特异性响应吲哚基团。当应用于血浆检测时,其可耐受生理条件下高浓度NaCl的影响,但会被痕量体系的HSA淬灭荧光,进而使得该体系可以实现用1μL血浆样本联合检测HSA。基于此,通过免处理或去蛋白样本前处理,最终实现了血浆白蛋白、游离色氨酸和总色氨酸的联合检测。值得注意的是,该体系建立了色氨酸及其载体白蛋白的快速无标记荧光检测方法。其仅需将无标记信号探针、捕获探针及待测样本进行混合,随后在紫外灯下照射30 min,即可于荧光酶标仪上测定信号,操作方便快捷,适于临床快速检测应用,将为脓毒症色氨酸及白蛋白监测提供便捷经济的检测技术。此外,我们借助靶向定量代谢组学进行了脓毒症代谢标志物筛选和分析,揭示了脓毒症从系统性炎症反应综合征发展为脓毒性休克临床不良结局的关键代谢标志物及其富集通路,尤其发现色氨酸下游代谢产物犬尿氨酸在这一转变过程中具有重要指示作用,进而可作为监测脓毒症疾病进展并预警其临床不良结局的重要代谢标志物。
国内基金
海外基金